The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Nationwide Population-Based Case-Control Study
Abstract
IMPORTANCE: Excess endogenous cortisol has been linked to venous thromboembolism (VTE) risk, but whether this relationship applies to exogenous glucocorticoids remains uncertain. Because the prevalence of glucocorticoid use and the incidence of VTE are high, an increased risk of VTE associated with glucocorticoid use would have important implications. BACKGROUND: To examine the association between glucocorticoid use and VTE. DESIGN: Population-based case-control study using nationwide databases. SETTING: Denmark (population 5.6 million). PARTICIPANTS: We identified 38,765 VTE cases diagnosed from January 1, 2005, through December 31, 2011, and 387,650 population controls included through risk-set sampling and matched by birth year and sex. The VTE diagnosis date for the case was the index date for cases and matched controls. EXPOSURE: We classified individuals who filled their most recent glucocorticoid prescription 90 days or less, 91 to 365 days, and more than 365 days before the index date as present, recent, and former users, respectively. Present users were subdivided into new (first-ever prescription 90 days or less before the index date) and continuing users (others). MAIN OUTCOMES AND MEASURES: We used conditional logistic regression adjusted for VTE risk factors to estimate incidence rate ratios (IRRs) and 95% CIs for glucocorticoid users vs nonusers. RESULTS: Systemic glucocorticoids increased VTE risk among present (adjusted IRR, 2.31; 95% CI, 2.18-2.45), new (3.06; 2.77-3.38), continuing (2.02; 1.88-2.17), and recent (1.18; 1.10-1.26) users but not among former users (0.94; 0.90-0.99). The adjusted IRR increased from 1.00 (95% CI, 0.93-1.07) for a prednisolone-equivalent cumulative dose of 10 mg or less to 1.98 (1.78-2.20) for more than 1000 to 2000 mg, and to 1.60 (1.49-1.71) for doses higher than 2000 mg. New use of inhaled (adjusted IRR, 2.21; 95% CI, 1.72-2.86) and intestinal-acting (2.17; 1.27-3.71) glucocorticoids also increased VTE risk. CONCLUSIONS AND RELEVANCE: The risk of VTE is increased among glucocorticoid users. Although residual confounding may partly explain this finding, we consider a biological mechanism likely because the association followed a clear temporal gradient, persisted after adjustment for indicators of severity of underlying disease, and existed also for noninflammatory conditions. Hence, our observations merit clinical attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
Thygesen, S. K., Christiansen, C. F., Christensen, S., Lash, T. L., & Sørensen, H. T. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-83 · Cited by 1,195
Self-citationVandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Self-citationThe Epidemiology of Venous Thromboembolism in the Community
Heit, J. A. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162545 · Cited by 778
Grainge, M. J., West, J., & Card, T. R. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61963-2 · Cited by 730
Schneeweiss, S. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1200 · Cited by 727
Inhaled Glucocorticoids for Asthma
Barnes, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321307 · Cited by 629
Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 616
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
Huerta, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.935 · Cited by 408
Johannesdottir, S. A., Horváth-Puhó, E., Ehrenstein, V., Schmidt, Pedersen, L., & Sørensen, H. (2012) · Clinical Epidemiology · doi:10.2147/clep.s37587 · Cited by 379
Self-citationZöller, B., Li, X., Sundquist, J., & Sundquist, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61306-8 · Cited by 366
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
Gangireddy, C., Rectenwald, J. R., Upchurch, G. R., Wakefield, T. W., Khuri, S., Henderson, W. G., & Henke, P. K. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.10.034 · Cited by 295
What Does the Odds Ratio Estimate in a Case-Control Study?
PEARCE, N. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.6.1189 · Cited by 266
[The national patient registry. Evaluation of data quality].
Mosbech, J., Jørgensen, J. O. L., Madsen, M., Rostgaard, K., Thornberg, K., & Poulsen, T. (1995) · PubMed · Cited by 222
Self-citationHypercoagulable State in Cushing’s Syndrome: A Systematic Review
Van Zaane, B., Nur, E., Squizzato, A., Dekkers, O. M., Twickler, M. (. B., Fliers, E., Gerdes, V. E. A., Büller, H. R., & Brandjes, D. P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0290 · Cited by 216
Self-citationVAN ZAANE, B., NUR, E., SQUIZZATO, A., GERDES, V. E. A., BÜLLER, H. R., DEKKERS, O. M., & BRANDJES, D. P. M. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04034.x · Cited by 210
Self-citationIncidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study
Stuijver, D. J. F., van Zaane, B., Feelders, R. A., Debeij, J., Cannegieter, S. C., Hermus, A. R., van den Berg, G., Pereira, A. M., de Herder, W. W., Wagenmakers, M. A. E. M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1661 · Cited by 208
Self-citationSeverinsen, M. T., Kristensen, S. R., Overvad, K., Dethlefsen, C., Tjønneland, A., & Johnsen, S. P. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.018 · Cited by 206
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers
Brotman, D. J., Girod, J. P., Posch, A., Jani, J. T., Patel, J. V., Gupta, M., Lip, G. Y. H., Reddy, S., & Kickler, T. S. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.06.006 · Cited by 173
An assessment of optimal hydrocortisone replacement therapy
Howlett, T. A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1340955.x · Cited by 169
Acute infections and venous thromboembolism
Schmidt, M., Horvath‐Puho, E., Thomsen, R. W., Smeeth, L., & Sørensen, H. T. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02473.x · Cited by 163
Self-citationBudesonide for maintenance of remission in Crohn's disease
Kuenzig, M. E., Rezaie, A., Seow, C. H., Otley, A. R., Steinhart, A. H., Griffiths, A. M., Kaplan, G. G., & Benchimol, E. I. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002913.pub3 · Cited by 160
Alén, J. C., Toloza, S., Fernández, M., Bastian, H. M., Fessler, B. J., Roseman, J. M., McGwin, G., Vilá, L. M., Reveille, J. D., Alarcón, G. S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21149 · Cited by 147
Oral Contraceptives and Venous Thromboembolism: A Systematic Review and Meta-Analysis
Manzoli, L., Vito, C. D., Marzuillo, C., Boccia, A., & Villari, P. (2012) · Drug Safety · doi:10.2165/11598050-000000000-00000 · Cited by 124
van Langevelde, K., Flinterman, L. E., Vlieg, A. V. H., Rosendaal, F. R., & Cannegieter, S. C. (2012) · Blood · doi:10.1182/blood-2012-02-407551 · Cited by 106
Self-citationThromboembolic disease in vasculitis
Tómasson, G., Monach, P. A., & Merkel, P. A. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32831de4e7 · Cited by 88
Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
Zamagni, E., Brioli, A., Tacchetti, P., Zannetti, B. A., Pantani, L., & Cavo, M. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273085 · Cited by 87
Non‐steroidal anti‐inflammatory drug use and risk of venous thromboembolism
Schmidt, M., Christiansen, C. F., Horváth–Puhó, E., Glynn, R. J., Rothman, K. J., & Sørensen, H. T. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04354.x · Cited by 79
Self-citationThe coagulation system in endocrine disorders: A narrative review
Squizzato, A., Gerdes, V. E. A., Ageno, W., & Buller, H. R. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0026-x · Cited by 68
Stolz, E. P., Klötzsch, C., Schlachetzki, F., & Rahimi, A. (2003) · European Neurology · doi:10.1159/000070197 · Cited by 56
Arlt, W. (2008) · Clinical Medicine · doi:10.7861/clinmedicine.8-2-211 · Cited by 55
Therapeutic doses of glucocorticoids: implications for oral medicine
Baid, S., & Nieman, L. K. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2006.01290.x · Cited by 41
Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study
Sørensen, G. V., Cronin-Fenton, D. P., Sørensen, H. T., Ulrichsen, S. P., Pedersen, L. H., & Lash, T. L. (2012) · Breast Cancer Research · doi:10.1186/bcr3106 · Cited by 39
Self-citationRisk assessment model for venothromboembolism in post-hospitalized patients.
Yale, S. H., Medlin, S. C., Liang, H., Peters, T., Glurich, I., & Mazza, J. J. (2005) · PubMed · Cited by 37
Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
Russell, M. W., Taylor, D. C. A., Cummins, G., & Huse, D. M. (2002) · PubMed · Cited by 31
Estimation of exposure-specific rates from sparse case-control data
Greenland, S. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90075-0 · Cited by 24
Cited by
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Heart Disease and Stroke Statistics—2014 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,215
Waljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830
“17 40-46 For sepsis, the outcome was admission to hospital for reason of sepsis (inpatient claims with a primary diagnosis of sepsis).”
BackgroundNordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries
Laugesen, K., Ludvigsson, J. F., Schmidt, M., Gissler, M., Valdimarsdottir, U. A., Lunde, A., & Sørensen, H. T. (2021) · Clinical Epidemiology · doi:10.2147/clep.s314959 · Cited by 543
Self-citationThe Role of Inflammation in Venous Thromboembolism
Branchford, B. R., & Carpenter, S. L. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00142 · Cited by 384
Metadata
- Authors
- Johannesdottir, S. A., Horváth-Puhó, E., Dekkers, O. M., Cannegieter, S. C., Jørgensen, J. O. L., Ehrenstein, V., Vandenbroucke, J. P., Pedersen, L., & Sørensen, H. T.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2013-05-13
- Volume
- 173
- Issue
- 9
- Pages
- 743
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2134766532
- Cited by
- 465
- References
- 40
- FWCI
- 20.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.